bangsal gin mg 1

7/26/2019 Bangsal GIN Mg 1

1/10

TOTAL PATIENT IN WARD

Ward Patients Total

New Patient Old Patient

1stEnim 3 2 5

2ndEnim 6 - 6

Mawar 2 11Lematan! 1 1 2

M"si Elo# 2 1 3

O!an 3 3 6

$asmin % 1 1 2

&enan!a A - - -

1' 1( 35

TOTAL PATIENT )$ *+)DI,I*ON

Patients Total

New Patient Old Patient.ne/olo!. 6 - 6

On/olo!. 2 11

Endo/rinolo!. - - -

+ro!.ne/olo!. 1 - 1

( 10 1(

.ne/olo!i/al Inatient %ie

Dr4 Ra#mat A#ar ( atients

Dr4 7on 8erians.a atients

Total atients 1' atients

NO Patient9s ID Dia!nosis Mana!ement P.si/ian

1. Mrs. SAR/39/P0A1/UA Ovarian Cancer inadequate

staging

Chemothera! "SR

#. Mrs. $U%/&1/P3A0/RA Stage ''' ( Cervica) cancer Chemothera! "SR

3. Mrs. "A'/#*/P0A0/UA Stage ''' +,- score '+O

3

Chemothera! "SR

&. Mrs. M%/1*/RA Stage ' C Ovarian Cancer Chemothera! "SR

. Mrs.R'S//P#A0/RA Cervica) cancer Stage ''' (

as susected

+enera) condition

imrovment

"SR

*. Mrs. %'/&2/UA/P&A0 Stage '' ( Cervica) cancer P)an or radica)

h!sterectom!

RA-

2. Mrs. -AU/*/UA/PA0 Uterine ro)ase grade ''' 4

C!stoc)e grade ''

P)an or ,56 4 7o)orai

anterior 4 SS

RA-

8. Mrs. UR//RA/P#A0 Stages ''' C Ovarian Cancer Chemothera! RA-

9. Mrs. 6OM/*3/UA/P1A1 Stages '5A Ovarian Cancer Chemothera! RA-

10. Mrs. SU-/20/UA/P10A3 Stage ''' ( Cervica) cancer Chemothera! :6"


2/10

11. Mrs. $U%/&&/UA/P0A0 Uterine m!oma P)an or M!omectom! RA-

1#. Mrs. RUS/2*/RA/P#A0 C!stic ovarian neo)asm

ma)ignanc! as susected

Chemothera! :6"

13 Mrs. SU/#2/+1P0A0/UA +1P0A0 9 ee7s gestationa)age ith threatened

a;ortion intrauterine

Medicina)is COR

1& Mrs. A+U/#2/+3P#A1/

UA

ctoic regnanc! as

susected

%aarosco! right

sa)h!ngostom!

RM

1 Ms. MAR/3#/UA Mu)ti)e uterine m!oma Medicina)is AS"

1* Mrs. PO"/*0/ P&A0/RA AU( e.c %1 Medicina)is 4 )an or

h!sterectom!

AS"

12 Mrs. R"/3#/ P0A#/UA 'ntramura) uterine m!oma P)an or 6-%O AS"

Dr4 Ra#mat A#ar Din"r

1 06406416 %emotera.

Mrs4 *AR:31: P0A1:+A:N*R

0&

M/ Chemothera! ac)ita?e)car;o)atin 5' course =1.11>

Patho)og! "o. P101990 (Ovarial : clear cell carcinoma


3/10

Omental : clear cell carcinoma metastatic

6 0(406416 %emotera.

Mrs4 8OM:63:+A:P1A1:RAD

0#Patho)og! "o. 302/A/#01*

! "igh grade serouse carcinoma ovarial that expanded to the cerviks wall, myometrium and right

and left fallopian tu#e

! "igh grade serouse carcinoma omental metastase

! high grade serouse carcinoma tunica serouse rectosigmoid metastase

$! high grade carcinoma invasion to su#mucosa appendic vascular

' 03406416 Plan or M.ome/tom.

Mrs4 $+L:;;:+A:P0A0:A*N

0M

0#.00 PM -/ ctoic regnanc! as susected =O00.9>

0*0*1* M/ %aarasco! sa)hingostom! de7stra =**.01>

"O ASSSM",Dr4 Ra#mat A#ar Din"r 5A%U MA "otes

1 Reort technique 30

# Paer ac7no)edgment 3

3 6onest! 3

Mean 100

Dr4 7on 8erians.a

1 0'406416 %emotera.

Mrs4 NAI:23: P0A1:+A:N*R03

M/ Chemothera! Methotre?ateRescovu)in 3rdcourse =1.11>

Patho)og! "o. PA 0311/PA/C6/#01*

"ydtidiform mole trofo#last cell complete proliferation

2 06406416 %emotera.

Msr4 *AN:5;:P;A0+A:N*R

11

M/ Chemothera! O?a)a)atin @ +emcita;in 1stcourse =1.11>

Patho)og! "o. PA ##12/A/#01*

Non keratinizing squamous cell carcinoma cervic,moderately differentiated

3 02406416 eneral /ondition imro?ment Mrs4RI*:;2:P2A0


4/10

:RA:N*R

-/Cervica) cancer stage ''' ( as susected 4 moderate anemia =C3.9>

M/+enera) condition imrovment

P)an or c)inica) staging

Patho)og! "o. PA SS.1*0&00&9

keratinizing squamous cell carcinoma cervic,moderately differentiated

; 26405416 %emotera.

Mrs4 *+D:'0:+A:P10A3:78N

02

M/ PRC transusion

P/ tota) a;domina) h!sterectom!

05406416 Plan or 8DLO

Mrs4 REN:32: P0A2:+A:A*N

0.30 PM -/ 'ntramura) uterine m!oma 4 secondar! inerti)e !ears =-#.1>

M/ P)an or 6-%O

Ostetri/al %ie on D"t. Dr4 7on 8erians.aT"esda.@ 7"ne 't@ 2016 at 03400 PM- T"rsda.@ 7"ne (t@ 2016 at 0'400 AM


5/10

%ons"ltant on D"t. Dr4 A4 Aadi@ *O&B

1.

07-06-1602:15 PM

Spontaneous deliveryMrs.

DAH/31/UA/RZM

Hb: 11.2 g/dLWBC: 9.100PLT 264.00LEA(-)

D/ G2P1A0 40 wee! ge!"#!$%' #ge $&'#b% !" !"#g'#"e&" *+#!e w$"+ P,M 1 d# e"#*'%"be3'%!$! w$"+ $&3%*'e"e "+e#* L 3e*+#'$*e!e&"#"$%&

US R =+'">

Sing)e )ie etus ceha)ic resentation

(iometr! Acce)eration ith o?!tocin dri

Consu)t to interna) deartment

P/ 5agina) de)iver!'nterna) -eartement A/ there is no sign o u)monar! ,(

03


6/10

19


7/10

6C < #*8 mm %< #.1 mm

D< 131& g

P)acenta in osterior corus o uterine

Amniotic )uid as enough

C/ #9 ee7s gestationa) ageB S% ceha)ic resentationM/ O;served vita) signB 6RB in)a;or signs

'5- R% ?? dros / mnt

%a;orator! e?amination

Urinar! catheter insertion

MgSO& inE F rotoco)

"iediine 10 mg/ 8 hours PO

Consu)t to interna) and ohtha)mo)og! deartment

-e7sametasone inEection 10 mg/1# hours

P/ ?ectative management

;4 0'-06-1602< 00 PM

Partial eCtra/tion

Mrs4 *RI:2:RA:A)

-/ +3P1A1 39 ee7s gestasiona) age in)a;or second stageB sing)e )ie

etus ;reech resentation

M/ o;s. 5ita) signB contractionB 6R

%a;orator! e?amination

'5- R% ?? dros/m

P/ conduct the )a;or02


8/10

Acce)eration ith o?!tocin dri

Consu)t to interna) and ohtha)mo)og! deartment

,u;a) )igation counse)ingB agree

P/ vagina) de)iver!

0(-06-16

01


9/10

histor! o CS 1?B S% ceha)ic resentation

US R

Sing)e )ie etus ceha)ic resentation

(iometr!

bangsal gin mg 1

Documents